These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9629592)

  • 1. Human variability and noncancer risk assessment--an analysis of the default uncertainty factor.
    Renwick AG; Lazarus NR
    Regul Toxicol Pharmacol; 1998 Feb; 27(1 Pt 1):3-20. PubMed ID: 9629592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human variability and noncancer risk assessment- An analysis of the default uncertainty factor.
    Renwick AG; Lazarus NR
    Regul Toxicol Pharmacol; 1998 Feb; 27(1 Pt 2):3-20. PubMed ID: 9618319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probabilistic framework for the estimation of the adult and child toxicokinetic intraspecies uncertainty factors.
    Pelekis M; Nicolich MJ; Gauthier JS
    Risk Anal; 2003 Dec; 23(6):1239-55. PubMed ID: 14641898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The refinement of uncertainty/safety factors in risk assessment by the incorporation of data on toxicokinetic variability in humans.
    Dorne JL; Renwick AG
    Toxicol Sci; 2005 Jul; 86(1):20-6. PubMed ID: 15800035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human variability in xenobiotic metabolism and pathway-related uncertainty factors for chemical risk assessment: a review.
    Dorne JL; Walton K; Renwick AG
    Food Chem Toxicol; 2005 Feb; 43(2):203-16. PubMed ID: 15621332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of inter-individual differences in drug metabolism and pharmacokinetics on safety evaluation.
    Dorne JL
    Fundam Clin Pharmacol; 2004 Dec; 18(6):609-20. PubMed ID: 15548231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the human kinetic adjustment factor for the health risk assessment of environmental contaminants.
    Valcke M; Krishnan K
    J Appl Toxicol; 2014 Mar; 34(3):227-40. PubMed ID: 24038072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism, variability and risk assessment.
    Dorne JL
    Toxicology; 2010 Feb; 268(3):156-64. PubMed ID: 19932147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human variability in hepatic and renal elimination: implications for risk assessment.
    Dorne JL
    J Appl Toxicol; 2007; 27(5):411-20. PubMed ID: 17497760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiological-model-based derivation of the adult and child pharmacokinetic intraspecies uncertainty factors for volatile organic compounds.
    Pelekis M; Gephart LA; Lerman SE
    Regul Toxicol Pharmacol; 2001 Feb; 33(1):12-20. PubMed ID: 11259175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of science-based uncertainty factors in noncancer risk assessment.
    Dourson ML; Felter SP; Robinson D
    Regul Toxicol Pharmacol; 1996 Oct; 24(2 Pt 1):108-20. PubMed ID: 8933624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human variability in influx and efflux transporters in relation to uncertainty factors for chemical risk assessment.
    Darney K; Turco L; Buratti FM; Di Consiglio E; Vichi S; Roudot AC; Béchaux C; Testai E; Dorne JLCM; Lautz LS
    Food Chem Toxicol; 2020 Jun; 140():111305. PubMed ID: 32234423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncertainty factors for chemical risk assessment: interspecies differences in glucuronidation.
    Walton K; Dorne JL; Renwick AG
    Food Chem Toxicol; 2001 Dec; 39(12):1175-90. PubMed ID: 11696391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity and reliability of in vitro systems in safety evaluation.
    Paine AJ
    Environ Toxicol Pharmacol; 1996 Oct; 2(2-3):207-12. PubMed ID: 21781729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Boron tolerable intake: re-evaluation of toxicokinetics for data-derived uncertainty factors.
    Dourson M; Maier A; Meek B; Renwick A; Ohanian E; Poirier K
    Biol Trace Elem Res; 1998; 66(1-3):453-63. PubMed ID: 10050937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the potential impact of benchmark dose and pharmacokinetic modeling in noncancer risk assessment.
    Clewell HJ; Gentry PR; Gearhart JM
    J Toxicol Environ Health; 1997 Dec; 52(6):475-515. PubMed ID: 9397182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A procedure for developing risk-based reference doses.
    Gaylor DW; Kodell RL
    Regul Toxicol Pharmacol; 2002 Apr; 35(2 Pt 1):137-41. PubMed ID: 12051999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the variability of the pharmacokinetics of multiple drugs in young adult and elderly subjects and its implications for acceptable daily exposures and cleaning validation limits.
    Streeter AJ; Faria EC
    Int J Hyg Environ Health; 2017 Jun; 220(4):659-672. PubMed ID: 28396010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability and uncertainty in Swedish exposure factors for use in quantitative exposure assessments.
    Filipsson M; Öberg T; Bergbäck B
    Risk Anal; 2011 Jan; 31(1):108-19. PubMed ID: 20723149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the interindividual human variation in bioactivation of methyleugenol using physiologically based kinetic modeling and Monte Carlo simulations.
    Al-Subeihi AA; Alhusainy W; Kiwamoto R; Spenkelink B; van Bladeren PJ; Rietjens IM; Punt A
    Toxicol Appl Pharmacol; 2015 Mar; 283(2):117-26. PubMed ID: 25549870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.